Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
Clinical trial NCT07243366 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07243366
- Sponsor
- Guangdong ProCapZoom Biosciences Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2027-06-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.